Frequent mutation of the p53 gene in human esophageal cancer (original) (raw)

Abstract

Sequence alterations in the p53 gene have been detected in human tumors of the brain, breast, lung, and colon, and it has been proposed that p53 mutations spanning a major portion of the coding region inactivate the tumor suppressor function of this gene. To our knowledge, neither transforming mutations in oncogenes nor mutations in tumor suppressor genes have been reported in human esophageal tumors. We examined four human esophageal carcinoma cell lines and 14 human esophageal squamous cell carcinomas by polymerase chain reaction amplification and direct sequencing for the presence of p53 mutations in exons 5, 6, 7, 8, and 9. Two cell lines and five of the tumor specimens contained a mutated allele (one frameshift and six missense mutations). All missense mutations detected occurred at G.C base pairs in codons at or adjacent to mutations previously reported in other cancers. The identification of aberrant p53 gene alleles in one-third of the tumors we tested suggests that mutations at this locus are common genetic events in the pathogenesis of squamous cell carcinomas of the esophagus.

9958

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ames B. N. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science. 1983 Sep 23;221(4617):1256–1264. doi: 10.1126/science.6351251. [DOI] [PubMed] [Google Scholar]
  2. Baker S. J., Fearon E. R., Nigro J. M., Hamilton S. R., Preisinger A. C., Jessup J. M., vanTuinen P., Ledbetter D. H., Barker D. F., Nakamura Y. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 1989 Apr 14;244(4901):217–221. doi: 10.1126/science.2649981. [DOI] [PubMed] [Google Scholar]
  3. Banks-Schlegel S. P., Quintero J. Growth and differentiation of human esophageal carcinoma cell lines. Cancer Res. 1986 Jan;46(1):250–258. [PubMed] [Google Scholar]
  4. Barbacid M. ras genes. Annu Rev Biochem. 1987;56:779–827. doi: 10.1146/annurev.bi.56.070187.004023. [DOI] [PubMed] [Google Scholar]
  5. Benzer S., Freese E. INDUCTION OF SPECIFIC MUTATIONS WITH 5-BROMOURACIL. Proc Natl Acad Sci U S A. 1958 Feb;44(2):112–119. doi: 10.1073/pnas.44.2.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bishop J. M. The molecular genetics of cancer. Science. 1987 Jan 16;235(4786):305–311. doi: 10.1126/science.3541204. [DOI] [PubMed] [Google Scholar]
  7. Bos J. L. The ras gene family and human carcinogenesis. Mutat Res. 1988 May;195(3):255–271. doi: 10.1016/0165-1110(88)90004-8. [DOI] [PubMed] [Google Scholar]
  8. Bos J. L. ras oncogenes in human cancer: a review. Cancer Res. 1989 Sep 1;49(17):4682–4689. [PubMed] [Google Scholar]
  9. Coulondre C., Miller J. H., Farabaugh P. J., Gilbert W. Molecular basis of base substitution hotspots in Escherichia coli. Nature. 1978 Aug 24;274(5673):775–780. doi: 10.1038/274775a0. [DOI] [PubMed] [Google Scholar]
  10. Eliyahu D., Raz A., Gruss P., Givol D., Oren M. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature. 1984 Dec 13;312(5995):646–649. doi: 10.1038/312646a0. [DOI] [PubMed] [Google Scholar]
  11. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. doi: 10.1016/0092-8674(90)90186-i. [DOI] [PubMed] [Google Scholar]
  12. Hecht S. S., Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis. 1988 Jun;9(6):875–884. doi: 10.1093/carcin/9.6.875. [DOI] [PubMed] [Google Scholar]
  13. Hinds P., Finlay C., Levine A. J. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol. 1989 Feb;63(2):739–746. doi: 10.1128/jvi.63.2.739-746.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hollstein M. C., Smits A. M., Galiana C., Yamasaki H., Bos J. L., Mandard A., Partensky C., Montesano R. Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers. Cancer Res. 1988 Sep 15;48(18):5119–5123. [PubMed] [Google Scholar]
  15. Horsfall M. J., Glickman B. W. Mutation site specificity of N-nitroso-N-methyl-N-alpha-acetoxybenzylamine: a model derivative of an esophageal carcinogen. Carcinogenesis. 1988 Sep;9(9):1529–1532. doi: 10.1093/carcin/9.9.1529. [DOI] [PubMed] [Google Scholar]
  16. Horsfall M. J., Gordon A. J., Burns P. A., Zielenska M., van der Vliet G. M., Glickman B. W. Mutational specificity of alkylating agents and the influence of DNA repair. Environ Mol Mutagen. 1990;15(2):107–122. doi: 10.1002/em.2850150208. [DOI] [PubMed] [Google Scholar]
  17. Hunts J., Ueda M., Ozawa S., Abe O., Pastan I., Shimizu N. Hyperproduction and gene amplification of the epidermal growth factor receptor in squamous cell carcinomas. Jpn J Cancer Res. 1985 Aug;76(8):663–666. [PubMed] [Google Scholar]
  18. Iggo R., Gatter K., Bartek J., Lane D., Harris A. L. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet. 1990 Mar 24;335(8691):675–679. doi: 10.1016/0140-6736(90)90801-b. [DOI] [PubMed] [Google Scholar]
  19. Jenkins J. R., Rudge K., Currie G. A. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53. Nature. 1984 Dec 13;312(5995):651–654. doi: 10.1038/312651a0. [DOI] [PubMed] [Google Scholar]
  20. Jiang W., Kahn S. M., Guillem J. G., Lu S. H., Weinstein I. B. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer. Oncogene. 1989 Jul;4(7):923–928. [PubMed] [Google Scholar]
  21. Lane D. P., Benchimol S. p53: oncogene or anti-oncogene? Genes Dev. 1990 Jan;4(1):1–8. doi: 10.1101/gad.4.1.1. [DOI] [PubMed] [Google Scholar]
  22. Lavi S. Carcinogen-mediated amplification of viral DNA sequences in simian virus 40-transformed Chinese hamster embryo cells. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6144–6148. doi: 10.1073/pnas.78.10.6144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lawley P. D. Mutagens as carcinogens: development of current concepts. Mutat Res. 1989 Jul;213(1):3–25. doi: 10.1016/0027-5107(89)90028-6. [DOI] [PubMed] [Google Scholar]
  24. Lindahl T. DNA repair enzymes. Annu Rev Biochem. 1982;51:61–87. doi: 10.1146/annurev.bi.51.070182.000425. [DOI] [PubMed] [Google Scholar]
  25. Lu S. H., Hsieh L. L., Luo F. C., Weinstein I. B. Amplification of the EGF receptor and c-myc genes in human esophageal cancers. Int J Cancer. 1988 Oct 15;42(4):502–505. doi: 10.1002/ijc.2910420406. [DOI] [PubMed] [Google Scholar]
  26. Mazur M., Glickman B. W. Sequence specificity of mutations induced by benzo[a]pyrene-7,8-diol-9,10-epoxide at endogenous aprt gene in CHO cells. Somat Cell Mol Genet. 1988 Jul;14(4):393–400. doi: 10.1007/BF01534647. [DOI] [PubMed] [Google Scholar]
  27. McCann J., Choi E., Yamasaki E., Ames B. N. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5135–5139. doi: 10.1073/pnas.72.12.5135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Miller E. C., Miller J. A. Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromolecules. Pharmacol Rev. 1966 Mar;18(1):805–838. [PubMed] [Google Scholar]
  29. Miller J. H. Mutational specificity in bacteria. Annu Rev Genet. 1983;17:215–238. doi: 10.1146/annurev.ge.17.120183.001243. [DOI] [PubMed] [Google Scholar]
  30. Mitra G., Pauly G. T., Kumar R., Pei G. K., Hughes S. H., Moschel R. C., Barbacid M. Molecular analysis of O6-substituted guanine-induced mutagenesis of ras oncogenes. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8650–8654. doi: 10.1073/pnas.86.22.8650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Montesano R., Hall J., Hollstein M., Mironov N., Wild C. P. Alkylation repair in human tissues. Basic Life Sci. 1990;53:437–452. doi: 10.1007/978-1-4613-0637-5_33. [DOI] [PubMed] [Google Scholar]
  32. Mullis K. B., Faloona F. A. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 1987;155:335–350. doi: 10.1016/0076-6879(87)55023-6. [DOI] [PubMed] [Google Scholar]
  33. Nigro J. M., Baker S. J., Preisinger A. C., Jessup J. M., Hostetter R., Cleary K., Bigner S. H., Davidson N., Baylin S., Devilee P. Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989 Dec 7;342(6250):705–708. doi: 10.1038/342705a0. [DOI] [PubMed] [Google Scholar]
  34. Ozawa S., Ueda M., Ando N., Abe O., Shimizu N. High incidence of EGF receptor hyperproduction in esophageal squamous-cell carcinomas. Int J Cancer. 1987 Mar 15;39(3):333–337. doi: 10.1002/ijc.2910390311. [DOI] [PubMed] [Google Scholar]
  35. Parada L. F., Land H., Weinberg R. A., Wolf D., Rotter V. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature. 1984 Dec 13;312(5995):649–651. doi: 10.1038/312649a0. [DOI] [PubMed] [Google Scholar]
  36. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Singer G. M., Chuan J., Roman J., Min-Hsin L., Lijinsky W. Nitrosamines and nitrosamine precursors in foods from Linxian, China, a high incidence area for esophageal cancer. Carcinogenesis. 1986 May;7(5):733–736. doi: 10.1093/carcin/7.5.733. [DOI] [PubMed] [Google Scholar]
  38. Soussi T., Caron de Fromentel C., Méchali M., May P., Kress M. Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53. Oncogene. 1987 Mar;1(1):71–78. [PubMed] [Google Scholar]
  39. Tahara E. Growth factors and oncogenes in human gastrointestinal carcinomas. J Cancer Res Clin Oncol. 1990;116(2):121–131. doi: 10.1007/BF01612665. [DOI] [PubMed] [Google Scholar]
  40. Takahashi T., Nau M. M., Chiba I., Birrer M. J., Rosenberg R. K., Vinocour M., Levitt M., Pass H., Gazdar A. F., Minna J. D. p53: a frequent target for genetic abnormalities in lung cancer. Science. 1989 Oct 27;246(4929):491–494. doi: 10.1126/science.2554494. [DOI] [PubMed] [Google Scholar]
  41. Thilly W. G. Mutational spectrometry in animal toxicity testing. Annu Rev Pharmacol Toxicol. 1990;30:369–385. doi: 10.1146/annurev.pa.30.040190.002101. [DOI] [PubMed] [Google Scholar]
  42. Tsuda T., Nakatani H., Matsumura T., Yoshida K., Tahara E., Nishihira T., Sakamoto H., Yoshida T., Terada M., Sugimura T. Amplification of the hst-1 gene in human esophageal carcinomas. Jpn J Cancer Res. 1988 May;79(5):584–588. doi: 10.1111/j.1349-7006.1988.tb00026.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Tsuda T., Tahara E., Kajiyama G., Sakamoto H., Terada M., Sugimura T. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. Cancer Res. 1989 Oct 15;49(20):5505–5508. [PubMed] [Google Scholar]
  44. Tsutsumi M., Sakamoto H., Yoshida T., Kakizoe T., Koiso K., Sugimura T., Terada M. Coamplification of the hst-1 and int-2 genes in human cancers. Jpn J Cancer Res. 1988 Apr;79(4):428–432. doi: 10.1111/j.1349-7006.1988.tb01609.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Umbenhauer D., Wild C. P., Montesano R., Saffhill R., Boyle J. M., Huh N., Kirstein U., Thomale J., Rajewsky M. F., Lu S. H. O(6)-methyldeoxyguanosine in oesophageal DNA among individuals at high risk of oesophageal cancer. Int J Cancer. 1985 Dec 15;36(6):661–665. doi: 10.1002/ijc.2910360607. [DOI] [PubMed] [Google Scholar]
  46. Wang Y., You M., Reynolds S. H., Stoner G. D., Anderson M. W. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine. Cancer Res. 1990 Mar 1;50(5):1591–1595. [PubMed] [Google Scholar]
  47. Weinstein I. B. The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture. Cancer Res. 1988 Aug 1;48(15):4135–4143. [PubMed] [Google Scholar]
  48. Whang-Peng J., Banks-Schlegel S. P., Lee E. C. Cytogenetic studies of esophageal carcinoma cell lines. Cancer Genet Cytogenet. 1990 Mar;45(1):101–120. doi: 10.1016/0165-4608(90)90073-j. [DOI] [PubMed] [Google Scholar]
  49. Yamamoto T., Kamata N., Kawano H., Shimizu S., Kuroki T., Toyoshima K., Rikimaru K., Nomura N., Ishizaki R., Pastan I. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res. 1986 Jan;46(1):414–416. [PubMed] [Google Scholar]
  50. Yu M. C., Garabrant D. H., Peters J. M., Mack T. M. Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus. Cancer Res. 1988 Jul 1;48(13):3843–3848. [PubMed] [Google Scholar]